nodes	percent_of_prediction	percent_of_DWPC	metapath
Minaprine—DRD2—nicotine dependence	0.878	1	CbGaD
Minaprine—DRD1—Dopamine receptors—DRD2—nicotine dependence	0.00624	0.0638	CbGpPWpGaD
Minaprine—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA6—nicotine dependence	0.00437	0.0447	CbGpPWpGaD
Minaprine—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00309	0.0316	CbGpPWpGaD
Minaprine—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA5—nicotine dependence	0.00282	0.0288	CbGpPWpGaD
Minaprine—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00241	0.0247	CbGpPWpGaD
Minaprine—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA3—nicotine dependence	0.0023	0.0235	CbGpPWpGaD
Minaprine—ACHE—midbrain—nicotine dependence	0.00208	0.0857	CbGeAlD
Minaprine—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNB2—nicotine dependence	0.00202	0.0207	CbGpPWpGaD
Minaprine—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00192	0.0196	CbGpPWpGaD
Minaprine—DRD1—midbrain—nicotine dependence	0.0019	0.0786	CbGeAlD
Minaprine—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA4—nicotine dependence	0.00184	0.0188	CbGpPWpGaD
Minaprine—CHRM1—cardiovascular system—nicotine dependence	0.00179	0.0739	CbGeAlD
Minaprine—HTR2B—cardiovascular system—nicotine dependence	0.00178	0.0735	CbGeAlD
Minaprine—MAOA—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00148	0.0152	CbGpPWpGaD
Minaprine—HTR2C—midbrain—nicotine dependence	0.00148	0.0611	CbGeAlD
Minaprine—HTR2B—Monoamine GPCRs—DRD2—nicotine dependence	0.00146	0.015	CbGpPWpGaD
Minaprine—MAOA—cardiovascular system—nicotine dependence	0.00146	0.0602	CbGeAlD
Minaprine—DRD1—Hypothetical Network for Drug Addiction—DRD2—nicotine dependence	0.00141	0.0145	CbGpPWpGaD
Minaprine—SLC6A4—midbrain—nicotine dependence	0.0014	0.0579	CbGeAlD
Minaprine—DRD1—Monoamine GPCRs—DRD2—nicotine dependence	0.00138	0.0141	CbGpPWpGaD
Minaprine—ACHE—brain—nicotine dependence	0.0013	0.0539	CbGeAlD
Minaprine—HTR2B—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00123	0.0126	CbGpPWpGaD
Minaprine—DRD1—brain—nicotine dependence	0.0012	0.0494	CbGeAlD
Minaprine—HTR2C—Monoamine GPCRs—DRD2—nicotine dependence	0.00118	0.0121	CbGpPWpGaD
Minaprine—DRD1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00116	0.0119	CbGpPWpGaD
Minaprine—MAOA—midbrain—nicotine dependence	0.00114	0.047	CbGeAlD
Minaprine—DRD2—midbrain—nicotine dependence	0.00113	0.0465	CbGeAlD
Minaprine—ACHE—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00108	0.011	CbGpPWpGaD
Minaprine—HTR2A—Monoamine GPCRs—DRD2—nicotine dependence	0.00102	0.0105	CbGpPWpGaD
Minaprine—ACHE—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00102	0.0105	CbGpPWpGaD
Minaprine—CHRM1—Monoamine GPCRs—DRD2—nicotine dependence	0.00102	0.0104	CbGpPWpGaD
Minaprine—MAOA—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00102	0.0104	CbGpPWpGaD
Minaprine—SLC6A4—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.000996	0.0102	CbGpPWpGaD
Minaprine—HTR2C—Amine ligand-binding receptors—DRD2—nicotine dependence	0.000992	0.0101	CbGpPWpGaD
Minaprine—MAOA—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.000965	0.00987	CbGpPWpGaD
Minaprine—HTR2A—cardiovascular system—nicotine dependence	0.00095	0.0392	CbGeAlD
Minaprine—HTR2C—brain—nicotine dependence	0.00093	0.0384	CbGeAlD
Minaprine—SLC6A4—brain—nicotine dependence	0.000881	0.0364	CbGeAlD
Minaprine—CHRM1—brain—nicotine dependence	0.000878	0.0363	CbGeAlD
Minaprine—HTR2B—brain—nicotine dependence	0.000873	0.0361	CbGeAlD
Minaprine—HTR2A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.000861	0.0088	CbGpPWpGaD
Minaprine—CHRM1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.000857	0.00876	CbGpPWpGaD
Minaprine—ACHE—Neuronal System—CHRNB3—nicotine dependence	0.000828	0.00847	CbGpPWpGaD
Minaprine—MAOA—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.000816	0.00834	CbGpPWpGaD
Minaprine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000796	0.00814	CbGpPWpGaD
Minaprine—MAOA—Biological oxidations—CYP2A7—nicotine dependence	0.000788	0.00805	CbGpPWpGaD
Minaprine—CHRM1—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.000786	0.00803	CbGpPWpGaD
Minaprine—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000786	0.00803	CbGpPWpGaD
Minaprine—ACHE—Neuronal System—CHRNA6—nicotine dependence	0.000785	0.00803	CbGpPWpGaD
Minaprine—MAOA—Neuronal System—CHRNB3—nicotine dependence	0.00078	0.00798	CbGpPWpGaD
Minaprine—HTR2A—midbrain—nicotine dependence	0.000742	0.0306	CbGeAlD
Minaprine—ACHE—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.000741	0.00757	CbGpPWpGaD
Minaprine—MAOA—Neuronal System—CHRNA6—nicotine dependence	0.00074	0.00756	CbGpPWpGaD
Minaprine—MAOA—brain—nicotine dependence	0.000715	0.0295	CbGeAlD
Minaprine—DRD2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000711	0.00726	CbGpPWpGaD
Minaprine—ACHE—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00071	0.00726	CbGpPWpGaD
Minaprine—DRD2—brain—nicotine dependence	0.000707	0.0292	CbGeAlD
Minaprine—MAOA—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.000698	0.00713	CbGpPWpGaD
Minaprine—MAOA—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.000669	0.00684	CbGpPWpGaD
Minaprine—SLC6A4—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000665	0.00679	CbGpPWpGaD
Minaprine—ACHE—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00066	0.00675	CbGpPWpGaD
Minaprine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000645	0.0066	CbGpPWpGaD
Minaprine—MAOA—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.000622	0.00636	CbGpPWpGaD
Minaprine—HTR2B—GPCR ligand binding—TAS2R16—nicotine dependence	0.000604	0.00618	CbGpPWpGaD
Minaprine—SLC6A4—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000603	0.00617	CbGpPWpGaD
Minaprine—HTR2A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.0006	0.00613	CbGpPWpGaD
Minaprine—DRD1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00057	0.00582	CbGpPWpGaD
Minaprine—ACHE—Neuronal System—GABRA4—nicotine dependence	0.000568	0.0058	CbGpPWpGaD
Minaprine—MAOA—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000545	0.00557	CbGpPWpGaD
Minaprine—ACHE—Neuronal System—CHRNB4—nicotine dependence	0.000544	0.00556	CbGpPWpGaD
Minaprine—SLC6A4—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000543	0.00555	CbGpPWpGaD
Minaprine—ACHE—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000538	0.0055	CbGpPWpGaD
Minaprine—MAOA—Neuronal System—GABRA4—nicotine dependence	0.000535	0.00547	CbGpPWpGaD
Minaprine—MAOA—Neuronal System—CHRNB4—nicotine dependence	0.000513	0.00524	CbGpPWpGaD
Minaprine—MAOA—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000507	0.00518	CbGpPWpGaD
Minaprine—ACHE—Neuronal System—CHRNA5—nicotine dependence	0.000506	0.00517	CbGpPWpGaD
Minaprine—MAOA—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000495	0.00506	CbGpPWpGaD
Minaprine—CHRM1—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.000489	0.005	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—TAS2R16—nicotine dependence	0.000487	0.00498	CbGpPWpGaD
Minaprine—MAOA—Neuronal System—CHRNA5—nicotine dependence	0.000477	0.00487	CbGpPWpGaD
Minaprine—ACHE—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000474	0.00484	CbGpPWpGaD
Minaprine—CHRM1—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.000469	0.00479	CbGpPWpGaD
Minaprine—HTR2A—brain—nicotine dependence	0.000466	0.0193	CbGeAlD
Minaprine—MAOA—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000446	0.00456	CbGpPWpGaD
Minaprine—DRD1—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00044	0.00449	CbGpPWpGaD
Minaprine—ACHE—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00043	0.0044	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—TAS2R16—nicotine dependence	0.00043	0.0044	CbGpPWpGaD
Minaprine—CYP2D6—brain—nicotine dependence	0.000425	0.0175	CbGeAlD
Minaprine—HTR2A—GPCR ligand binding—TAS2R16—nicotine dependence	0.000423	0.00433	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000421	0.0043	CbGpPWpGaD
Minaprine—ACHE—Neuronal System—CHRNA3—nicotine dependence	0.000412	0.00422	CbGpPWpGaD
Minaprine—MAOA—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000405	0.00414	CbGpPWpGaD
Minaprine—SLC6A4—Circadian rythm related genes—DRD2—nicotine dependence	0.000401	0.0041	CbGpPWpGaD
Minaprine—HTR2A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.0004	0.00409	CbGpPWpGaD
Minaprine—HTR2B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00039	0.00399	CbGpPWpGaD
Minaprine—MAOA—Neuronal System—CHRNA3—nicotine dependence	0.000389	0.00397	CbGpPWpGaD
Minaprine—DRD1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000368	0.00376	CbGpPWpGaD
Minaprine—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000364	0.00372	CbGpPWpGaD
Minaprine—HTR2A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000363	0.00371	CbGpPWpGaD
Minaprine—ACHE—Neuronal System—CHRNB2—nicotine dependence	0.000363	0.00371	CbGpPWpGaD
Minaprine—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000343	0.0035	CbGpPWpGaD
Minaprine—MAOA—Neuronal System—CHRNB2—nicotine dependence	0.000342	0.0035	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000341	0.00349	CbGpPWpGaD
Minaprine—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000338	0.00346	CbGpPWpGaD
Minaprine—HTR2B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000335	0.00342	CbGpPWpGaD
Minaprine—DRD2—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000332	0.00339	CbGpPWpGaD
Minaprine—ACHE—Neuronal System—CHRNA4—nicotine dependence	0.00033	0.00337	CbGpPWpGaD
Minaprine—DRD1—Circadian rythm related genes—DRD2—nicotine dependence	0.000325	0.00332	CbGpPWpGaD
Minaprine—CHRM1—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000325	0.00332	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000322	0.00329	CbGpPWpGaD
Minaprine—DRD1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000315	0.00322	CbGpPWpGaD
Minaprine—HTR2C—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000315	0.00322	CbGpPWpGaD
Minaprine—MAOA—Neuronal System—CHRNA4—nicotine dependence	0.000311	0.00318	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—TAS2R16—nicotine dependence	0.00031	0.00317	CbGpPWpGaD
Minaprine—DRD2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.0003	0.00306	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000292	0.00299	CbGpPWpGaD
Minaprine—HTR2B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000282	0.00289	CbGpPWpGaD
Minaprine—DRD2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000278	0.00284	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000275	0.00282	CbGpPWpGaD
Minaprine—HTR2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000274	0.0028	CbGpPWpGaD
Minaprine—CHRM1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000272	0.00278	CbGpPWpGaD
Minaprine—HTR2C—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00027	0.00276	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—FGD1—nicotine dependence	0.000268	0.00274	CbGpPWpGaD
Minaprine—DRD1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000266	0.00272	CbGpPWpGaD
Minaprine—HTR2B—GPCR ligand binding—OPRM1—nicotine dependence	0.000255	0.0026	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—FGD1—nicotine dependence	0.000253	0.00258	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—TAS2R16—nicotine dependence	0.00025	0.00256	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—FGD1—nicotine dependence	0.000243	0.00249	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000243	0.00249	CbGpPWpGaD
Minaprine—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000242	0.00247	CbGpPWpGaD
Minaprine—DRD1—GPCR ligand binding—OPRM1—nicotine dependence	0.00024	0.00246	CbGpPWpGaD
Minaprine—CHRM1—Circadian rythm related genes—DRD2—nicotine dependence	0.00024	0.00246	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000239	0.00245	CbGpPWpGaD
Minaprine—DRD2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000238	0.00243	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000238	0.00243	CbGpPWpGaD
Minaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000234	0.0024	CbGpPWpGaD
Minaprine—CHRM1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000233	0.00238	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—FGD1—nicotine dependence	0.000229	0.00235	CbGpPWpGaD
Minaprine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000228	0.00233	CbGpPWpGaD
Minaprine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000228	0.00233	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000221	0.00226	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000217	0.00222	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—FGD1—nicotine dependence	0.000216	0.00221	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000216	0.00221	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—OPRM1—nicotine dependence	0.000206	0.0021	CbGpPWpGaD
Minaprine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000198	0.00202	CbGpPWpGaD
Minaprine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000197	0.00201	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—FGD1—nicotine dependence	0.000196	0.00201	CbGpPWpGaD
Minaprine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000195	0.00199	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—FGD1—nicotine dependence	0.000191	0.00195	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000188	0.00192	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—FGD1—nicotine dependence	0.000187	0.00191	CbGpPWpGaD
Minaprine—HTR2B—GPCR ligand binding—DRD2—nicotine dependence	0.000184	0.00188	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—TAS2R16—nicotine dependence	0.000183	0.00187	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—OPRM1—nicotine dependence	0.000181	0.00185	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000178	0.00182	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—OPRM1—nicotine dependence	0.000178	0.00181	CbGpPWpGaD
Minaprine—DRD1—GPCR ligand binding—DRD2—nicotine dependence	0.000174	0.00178	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—FGD1—nicotine dependence	0.000173	0.00177	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—TAS2R16—nicotine dependence	0.000173	0.00177	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—FGD1—nicotine dependence	0.00017	0.00174	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—FGD1—nicotine dependence	0.00017	0.00173	CbGpPWpGaD
Minaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000169	0.00173	CbGpPWpGaD
Minaprine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000169	0.00172	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—DRD2—nicotine dependence	0.000149	0.00152	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—TAS2R16—nicotine dependence	0.000148	0.00151	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—OPRM1—nicotine dependence	0.000144	0.00147	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—FGD1—nicotine dependence	0.000144	0.00147	CbGpPWpGaD
Minaprine—ACHE—Metabolism—CYP2A7—nicotine dependence	0.000143	0.00146	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000136	0.00139	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—FGD1—nicotine dependence	0.000136	0.00139	CbGpPWpGaD
Minaprine—MAOA—Metabolism—CYP2A7—nicotine dependence	0.000135	0.00138	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—OPRM1—nicotine dependence	0.000131	0.00134	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—TAS2R16—nicotine dependence	0.00013	0.00133	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—DRD2—nicotine dependence	0.000129	0.00132	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—TAS2R16—nicotine dependence	0.000128	0.00131	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—DRD2—nicotine dependence	0.000128	0.00131	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—TAS2R16—nicotine dependence	0.000128	0.0013	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—AKR1B10—nicotine dependence	0.000127	0.0013	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—OPRM1—nicotine dependence	0.000123	0.00126	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—AKR1B10—nicotine dependence	0.00012	0.00122	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—OPRM1—nicotine dependence	0.000116	0.00119	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—FGD1—nicotine dependence	0.000116	0.00119	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—OPRM1—nicotine dependence	0.000105	0.00108	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—DRD2—nicotine dependence	0.000104	0.00106	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—OPRM1—nicotine dependence	0.000102	0.00105	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—AKR1B10—nicotine dependence	0.000102	0.00105	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—FGD1—nicotine dependence	0.000102	0.00105	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000101	0.00103	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—FGD1—nicotine dependence	0.000101	0.00103	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—OPRM1—nicotine dependence	0.0001	0.00103	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—FGD1—nicotine dependence	0.0001	0.00102	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—DRD2—nicotine dependence	9.81e-05	0.001	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—DRD2—nicotine dependence	9.45e-05	0.000966	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—OPRM1—nicotine dependence	9.31e-05	0.000951	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—OPRM1—nicotine dependence	9.16e-05	0.000936	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—OPRM1—nicotine dependence	9.11e-05	0.000931	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—AKR1B10—nicotine dependence	9.04e-05	0.000924	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—WASF2—nicotine dependence	8.95e-05	0.000914	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—DRD2—nicotine dependence	8.91e-05	0.000911	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—AKR1B10—nicotine dependence	8.9e-05	0.000909	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—AKR1B10—nicotine dependence	8.85e-05	0.000904	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—WASF1—nicotine dependence	8.58e-05	0.000877	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—WASF2—nicotine dependence	8.44e-05	0.000862	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—DRD2—nicotine dependence	8.4e-05	0.000858	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—WASF1—nicotine dependence	8.09e-05	0.000827	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—OPRM1—nicotine dependence	7.72e-05	0.000789	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—DRD2—nicotine dependence	7.62e-05	0.000779	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—DRD2—nicotine dependence	7.29e-05	0.000745	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—OPRM1—nicotine dependence	7.28e-05	0.000744	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—DRD2—nicotine dependence	7.25e-05	0.000741	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—WASF2—nicotine dependence	7.22e-05	0.000738	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—WASF1—nicotine dependence	6.92e-05	0.000707	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—DRD2—nicotine dependence	6.62e-05	0.000677	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—DRD2—nicotine dependence	6.59e-05	0.000673	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—WASF2—nicotine dependence	6.37e-05	0.000651	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—WASF2—nicotine dependence	6.27e-05	0.000641	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—WASF2—nicotine dependence	6.23e-05	0.000637	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—OPRM1—nicotine dependence	6.23e-05	0.000637	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—WASF1—nicotine dependence	6.11e-05	0.000624	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—WASF1—nicotine dependence	6.01e-05	0.000614	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—WASF1—nicotine dependence	5.98e-05	0.000611	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CYP2A7—nicotine dependence	5.86e-05	0.000599	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—DRD2—nicotine dependence	5.58e-05	0.000571	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—OPRM1—nicotine dependence	5.5e-05	0.000562	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—OPRM1—nicotine dependence	5.41e-05	0.000553	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—OPRM1—nicotine dependence	5.38e-05	0.00055	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—DRD2—nicotine dependence	5.27e-05	0.000538	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—DRD2—nicotine dependence	4.5e-05	0.00046	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—DRD2—nicotine dependence	3.91e-05	0.0004	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—DRD2—nicotine dependence	3.89e-05	0.000398	CbGpPWpGaD
